Д.Уранчимэг
Loading...
Товч нэр
Д.Уранчимэг
Бүтэн нэр
Даваацэрэн Уранчимэг
Латин нэр
Davaatseren Uranchimeg
Эрдмийн цол
Профессор
Харьяалал
ORCID
Scopus Author ID
Now showing 1 - 2 of 2
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Efficacy of Intravitreal Bevacizumab in Neovascular Age-Related Macular Degeneration(Mongolian National University of Medical Sciences, 2022-12-29); ; ; ;Baasankhuu JamianjavObjective: To study the effect of cataract surgery with intravitreal bevacizumab therapy on visual and anatomical outcomes in patients with neovascular age-related macular degeneration (AMD) in Mongolian patients. Methods: A retrospective analysis of 72 eyes of 36 patients with neovascular AMD evaluated intravitreal bevacizumab (1or2.5 mg) injections. Retreatment was performed following an optical coherence tomography (OCT)-based regimen. Ophthalmic examination included best-corrected visual acuity (BCVA), dilated fundus examination, and OCT image analysis. Results: A total of 11 patients received cataract surgery. We could not observe statistical significance between the two groups. The BCVA of the right eye of patients having cataract surgery improved by 0.21 ± 0.29, while the corresponding value for patients without surgery was 0.32 ± 0.32. The mean central retinal thickness (CRT) of patients with refraction was decreased from 264.4 ± 82.32 μm at baseline to 244.55 ± 52.59 μm for the right eye, while it was 275.4 ± 96.4 μm at baseline to 276.36 ± 68.22 μm for the left eye. Conclusion: Cataract surgery with intravitreal bevacizumab therapy in eyes with neovascular AMD in aged patients was performed. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Trifocal Intraocular Lens Implantation to Treat Visual Demands in Mongolian Patients(Mongolian National University of Medical Sciences, 2022-04-01); ; Objective: Intraocular lens (IOL) implants are artificial lenses which helps to clear up the vision after cataract surgery. In this work, we aimed to compare the monofocal and trifocal IOL implantation during phacoemulsification. Methods: 60 eyes of 60 patients were divided into 2 equal groups. Postoperative astigmatism and UCVA were measured and compared during week 1, week 2 and month. Results: The mean preoperative UCVA was 6.83 ± 4.61 in the monofocal IOL group, and 17.5 ± 17.55 in the trifocal IOL group. At the first week: The mean postoperative UCVA at one week was 35.46 ± 19.45 and 58.64 ± 20.77, in each group respectively. The mean postoperative BCVA in the first week was 42.71 ± 20.63 and 65.91 ± 20.85, in each group respectively. The mean postoperative UCVA at 1 month was 46.57 ± 24.37 and 76.36 ± 23.61, in each group, while BCVA was 63.14 ± 24.94 and 89.54 ± 14.63. There was a highly significant statistical difference between the result of UCVA preoperative and the results of UCVA at the early and last postoperative follow up. Conclusion: From our results, it is evident that post-operative near UCVA and BCVA was statistically significant at monofocal and trifocal groups.
